Ten years' experience with pulmonary autograft replacements for aortic valve disease.
Pulmonary autograft valves have been used to replace isolated, diseased aortic valves for 10 years, with a long-term survival of 73%. The low incidence of degeneration supports the principle that the autograft valve is a potentially permanent valve replacement. Operative mortality is now less than 5%, despite the longer, more complex operation. The current use of fresh homograft valves for the pulmonary replacement has contributed to these excellent long-term results.
D000293:Adolescent; D000328:Adult; D001021:Aortic Valve; D001705:Bioprosthesis; D002648:Child; D005260:Female; D006349:Heart Valve Diseases / Q000401:mortality / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000401:mortality; D011664:Pulmonary Valve / Q000637:transplantation*; D012306:Risk; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous